| Recruiting | Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in Advanced Ovaria Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer | Phase 3 | 2022-09-13 |
| Active Not Recruiting | Trial on Radical Upfront Surgery in Advanced Ovarian Cancer Ovarian Cancer | N/A | 2016-07-01 |
| Completed | Evaluation of Optimal Treatment Duration of Bevacizumab Combination With Standard Chemotherapy in Patients Wit Genital Diseases, Female, Ovarian Diseases, Ovarian Neoplasms | Phase 3 | 2011-11-01 |
| Completed | Efficacy,Tolerability,Safety of Temsirolimus in Women With Platinum-refractory Ovarian Carcinoma or Advanced E Genital Diseases, Female, Ovarian Diseases, Ovarian Neoplasms | Phase 2 | 2011-10-01 |
| Completed | Chemo- and Radiotherapy in Epithelial Vulvar Cancer Radio/Chemotherapy in Node Positive Advanced Vulvar Cancer | — | 2011-02-01 |
| Completed | Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Canc Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cavity Cancer | N/A | 2010-07-01 |
| Completed | Multicenter Trial With PegLiposomal Doxorubicin and Carboplatin Combination Chemotherapy in Gynecological Sarc Mesenchymal Tumor, Carcinosarcoma, Leiomyosarcoma | Phase 2 | 2008-06-01 |
| Completed | Randomized Multicenter Trial With SU11248 Evaluating Dosage,Tolerability,Toxicity and Effectiveness of a Multi Platinum Refractory Epithelial Ovarian Cancer, Primary Cancer of the Peritoneum, Cancer of the Fallopian Tube | Phase 2 | 2007-09-01 |
| Completed | Validation of a Score of Predictive Factors for Complete Resection in Platinum-sensitive Recurrent Ovarian Can Ovarian Cancer | — | 2006-09-01 |
| Completed | Comparison of Paclitaxel/Carboplatin and Lonafarnib to Paclitaxel/Carboplatin for First-line Treatment of Ovar Epithelial Ovarian Cancer | Phase 2 | 2006-01-01 |
| Completed | Randomized, Multicenter, 2-Dose Level. Open-Label, Phase IIa Study With the Intraperitoneally Infused Trifunct Ovarian Cancer, Fallopian Tube Neoplasms, Peritoneal Neoplasms | Phase 2 | 2004-05-01 |
| Terminated | Reinduction Chemotherapy Containing Carboplatin and Paclitaxel With or Without Epoetin Alpha in Recurrent Plat Epithelial Ovarian Cancer, Fallopian Tube or Peritoneum, Platinum Sensitve Relapse, Anemia | Phase 3 | 2004-02-01 |
| Completed | Use of ACA 125 in Patients With Ovarian Cancer: Safety and Immune Response Ovarian Cancer, Fallopian Tube Neoplasms, Peritoneal Neoplasms | Phase 1 / Phase 2 | 2003-07-01 |
| Completed | Combination Chemotherapy Consisting of Pegylated Liposomal Doxorubicin and Carboplatin in Malignant Gynecologi Cancer of the Ovary Treated as 2nd Line Therapy, Muellerian Mixed Tumours, Tumours of the Uterus | Phase 2 | 2003-06-01 |
| Completed | Carboplatin/Paclitaxel +/-Gemcitabine in Treating Patients With Ovarian Epithelial or Fallopian Tube Cancer Fallopian Tube Cancer, Ovarian Cancer | Phase 3 | 2002-08-01 |
| Completed | Epoetin Beta in Treating Anemia in Patients With Cervical Cancer Anemia, Cervical Cancer | Phase 4 | 2002-07-01 |
| Completed | Liposomal Doxorubicin and Carboplatin in Treating Patients With Gynecologic Cancer Cervical Cancer, Endometrial Cancer, Fallopian Tube Cancer | Phase 1 / Phase 2 | 2001-08-01 |
| Completed | Combination Chemotherapy in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer | Phase 2 | 2001-08-01 |
| Completed | Paclitaxel Plus Carboplatin With or Without Topotecan in Treating Patients With Stage IIB, Stage III, or Stage Fallopian Tube Cancer, Ovarian Cancer | Phase 3 | 1999-12-01 |
| Completed | Paclitaxel, Carboplatin, and Topotecan in Patients With Ovarian Cancer Ovarian Cancer | Phase 3 | 1999-12-01 |
| Completed | Carboplatin With or Without Gemcitabine in Treating Patients With Advanced Ovarian Epithelial Cancer That Has Ovarian Cancer | Phase 3 | 1999-09-01 |
| Completed | Gemcitabine Plus Carboplatin Versus Carboplatin Monotherapy in Patients With Advanced Ovarian Cancer Ovarian Cancer | Phase 3 | 1999-09-01 |
| Completed | A Phase II Study of ZD1839 and Tamoxifen in Patients With Epithelial Ovarian Carcinoma, Cancer of the Fallopia Ovarian Cancer, Cancer of the Fallopian Tube, Peritoneal Cancer | Phase 2 | — |